Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$25,202,425
+$5,432,889 QoQ
Shares Held
21,012
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#795
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $78,680,706 across 9 Drug Manufacturers - General names. LLY ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
21,012 | $25,202,425 | |
| 2 | JNJ |
Johnson & Johnson
|
63,968 | $16,245,952 | |
| 3 | ABBV |
AbbVie Inc.
|
46,949 | $11,814,246 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,631 | $8,433,583 | |
| 5 | AMGN |
Amgen Inc
|
14,346 | $5,194,973 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
32,954 | $4,163,408 | |
| 7 | PFE |
Pfizer Inc
|
151,478 | $3,647,590 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
54,255 | $3,126,173 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,202,425 | 21,012 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $19,769,536 | 21,494 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $23,206,642 | 21,594 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $29,318,275 | 38,425 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $32,059,730 | 41,127 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $34,488,349 | 41,758 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $32,692,656 | 42,348 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $38,654,448 | 43,631 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $41,562,374 | 45,906 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $36,539,225 | 46,968 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $29,457,862 | 50,535 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $30,732,967 | 57,217 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $31,030,061 | 66,165 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $23,008,796 | 66,999 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $24,398,601 | 66,692 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $21,650,545 | 66,957 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $21,631,004 | 66,715 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $19,363,480 | 67,617 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $18,934,052 | 68,547 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $15,683,905 | 67,881 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $15,771,466 | 68,715 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $12,916,361 | 69,138 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $12,025,966 | 71,227 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $10,806,644 | 73,008 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $12,870,398 | 78,392 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $11,608,228 | 83,681 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||